Australia Stock Exchange release from AROVELLA THERAPE : Quarterly Appendix 4C and Activities Report
30/01/2022 21:34
Australia Stock Exchange release from AROVELLA THERAPE ALA.AX : Quarterly Appendix 4C and Activities Report
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO